{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:34:22Z","timestamp":1791462862894,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K07544"],"award-info":[{"award-number":["18K07544"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Becker muscular dystrophy (BMD) is caused by specific mutations in the <jats:italic>DMD<\/jats:italic> gene that causes progressive muscle weakness and primarily affects skeletal and cardiac muscle. Although cardiac involvement is a significant cause of mortality in BMD, the genetic\u2013phenotype correlation for skeletal and cardiac muscles has not been elucidated. Here, we described a 39-year-old man with BMD, who presented with subtle skeletal muscle weakness in the right leg in his 20s and underwent left ventricular restoration for severe dilated cardiomyopathy at the age of 29. He had difficulty climbing stairs after the age of 35. Neither duplication nor deletion of exons was detected by multiplex ligation-dependent probe amplification. A hemizygous c.264\u2009+\u20091G&gt;A mutation in intron 4 of the <jats:italic>DMD<\/jats:italic> was identified by next-generation sequencing. Furthermore, exon 4 skipping of the <jats:italic>DMD<\/jats:italic> was confirmed in both skeletal and cardiac muscles evaluated by reverse transcriptase PCR. Endomyocardial and skeletal muscle biopsies revealed dystrophic pathology characterized by muscle fiber atrophy and hypertrophy with a mild degree of interstitial fibrosis. Interestingly, dystrophin immunohistochemistry demonstrated patchy and faint staining of the skeletal muscle membranes but almost normal staining of the cardiac muscle membranes. Western blot analysis revealed a decreased amount of truncated dystrophin in skeletal muscle but surprisingly almost normal amount in cardiac muscle. This case indicates that BMD patients may have severe cardiac dysfunction despite preserved cardiac truncated dystrophin expression.<\/jats:p>","DOI":"10.1038\/s10038-020-0788-9","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T04:17:12Z","timestamp":1591330632000},"page":"903-909","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Severe cardiac involvement with preserved truncated dystrophin expression in Becker muscular dystrophy by +1G&gt;A DMD splice-site mutation: a case report"],"prefix":"10.1038","volume":"65","author":[{"given":"Ryouhei","family":"Komaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Mori-Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hotake","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narihiro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9452-112X","authenticated-orcid":false,"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9038-7506","authenticated-orcid":false,"given":"Yoshitsugu","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"788_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH Jr., Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919\u201328.","journal-title":"Cell."},{"key":"788_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/jcdd4010003","volume":"4","author":"T Tsuda","year":"2017","unstructured":"Tsuda T, Fitzgerald KK. Dystrophic cardiomyopathy: complex pathobiological processes to generate clinical phenotype. J Cardiovasc Dev Dis. 2017;4:3.","journal-title":"J Cardiovasc Dev Dis"},{"key":"788_CR3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/humu.20976","volume":"30","author":"S Tuffery-Giraud","year":"2009","unstructured":"Tuffery-Giraud S, Beroud C, Leturcq F, Yaou RB, Hamroun D, Michel-Calemard L, et al. Genotype-phenotype analysis in 2405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum Mutat. 2009;30:934\u201345.","journal-title":"Hum Mutat."},{"key":"788_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mus.880180304","volume":"18","author":"G Nigro","year":"1995","unstructured":"Nigro G, Comi LI, Politano L, Limongelli FM, Nigro V, De Rimini ML, et al. Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve. 1995;18:283\u201391.","journal-title":"Muscle Nerve."},{"key":"788_CR5","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ahj.2008.01.018","volume":"155","author":"DM Connuck","year":"2008","unstructured":"Connuck DM, Sleeper LA, Colan SD, Cox GF, Towbin JA, Lowe AM, et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J. 2008;155:998\u20131005.","journal-title":"Am Heart J"},{"key":"788_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0703-4","volume":"12","author":"M Okubo","year":"2017","unstructured":"Okubo M, Goto K, Komaki H, Nakamura H, Mori-Yoshimura M, Hayashi YK, et al. Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan. Orphanet J Rare Dis. 2017;12:149.","journal-title":"Orphanet J Rare Dis"},{"key":"788_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/jhg.2016.7","volume":"61","author":"M Okubo","year":"2016","unstructured":"Okubo M, Minami N, Goto K, Goto Y, Noguchi S, Mitsuhashi S, et al. Genetic diagnosis of Duchenne\/Becker muscular dystrophy using next-generation sequencing: validation analysis of DMD mutations. J Hum Genet. 2016;61:483\u20139.","journal-title":"J Hum Genet"},{"key":"788_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/jhg.2015.43","volume":"60","author":"R Guo","year":"2015","unstructured":"Guo R, Zhu G, Zhu H, Ma R, Peng Y, Liang D, et al. DMD mutation spectrum analysis in 613 Chinese patients with dystrophinopathy. J Hum Genet. 2015;60:435\u201342.","journal-title":"J Hum Genet"},{"key":"788_CR9","doi-asserted-by":"publisher","first-page":"e59916","DOI":"10.1371\/journal.pone.0059916","volume":"8","author":"J Juan-Mateu","year":"2013","unstructured":"Juan-Mateu J, Gonzalez-Quereda L, Rodriguez MJ, Verdura E, Lazaro K, Jou C, et al. Interplay between DMD point mutations and splicing signals in Dystrophinopathy phenotypes. PLoS ONE. 2013;8:e59916.","journal-title":"PLoS ONE."},{"key":"788_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13353-018-0444-7","volume":"59","author":"A Anna","year":"2018","unstructured":"Anna A, Monika G. Splicing mutations in human genetic disorders: examples, detection, and confirmation. J Appl Genet. 2018;59:253\u201368.","journal-title":"J Appl Genet"},{"key":"788_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/jmg.2008.061259","volume":"46","author":"Y Habara","year":"2009","unstructured":"Habara Y, Takeshima Y, Awano H, Okizuka Y, Zhang Z, Saiki K, et al. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G->A mutations in introns of the dystrophin gene. J Med Genet. 2009;46:542\u20137.","journal-title":"J Med Genet"},{"key":"788_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","volume":"2","author":"F Muntoni","year":"2003","unstructured":"Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2003;2:731\u201340.","journal-title":"Lancet Neurol"},{"key":"788_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/CIRCGENETICS.109.867242","volume":"2","author":"RW Kaspar","year":"2009","unstructured":"Kaspar RW, Allen HD, Ray WC, Alvarez CE, Kissel JT, Pestronk A, et al. Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in Becker muscular dystrophy. Circ Cardiovasc Genet. 2009;2:544\u201351.","journal-title":"Circ Cardiovasc Genet"},{"key":"788_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/ph8020303","volume":"8","author":"A Nakamura","year":"2015","unstructured":"Nakamura A. X-linked dilated cardiomyopathy: a cardiospecific phenotype of dystrophinopathy. Pharmaceuticals. 2015;8:303\u201320.","journal-title":"Pharmaceuticals"},{"key":"788_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1172\/JCI118112","volume":"96","author":"F Muntoni","year":"1995","unstructured":"Muntoni F, Wilson L, Marrosu G, Marrosu MG, Cianchetti C, Mestroni L, et al. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Investig. 1995;96:693\u20139.","journal-title":"J Clin Investig"},{"key":"788_CR16","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nm737","volume":"8","author":"D Xiong","year":"2002","unstructured":"Xiong D, Lee GH, Badorff C, Dorner A, Lee S, Wolf P, et al. Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease. Nat Med. 2002;8:872\u20137.","journal-title":"Nat Med."},{"key":"788_CR17","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1006\/jmcc.1997.0568","volume":"29","author":"RD Bies","year":"1997","unstructured":"Bies RD, Maeda M, Roberds SL, Holder E, Bohlmeyer T, Young JB, et al. A 5\u2019 dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy. J Mol Cell Cardiol. 1997;29:3175\u201388.","journal-title":"J Mol Cell Cardiol"},{"key":"788_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1096-7192(02)00153-1","volume":"77","author":"J Feng","year":"2002","unstructured":"Feng J, Yan J, Buzin CH, Towbin JA, Sommer SS. Mutations in the dystrophin gene are associated with sporadic dilated cardiomyopathy. Mol Genet Metab. 2002;77:119\u201326.","journal-title":"Mol Genet Metab"},{"key":"788_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0014-5793(02)02739-4","volume":"520","author":"A Nakamura","year":"2002","unstructured":"Nakamura A, Yoshida K, Takeda S, Dohi N, Ikeda S. Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise, in hearts of mdx mice. FEBS Lett. 2002;520:18\u201324.","journal-title":"FEBS Lett."},{"key":"788_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/000331970105200508","volume":"52","author":"M Saotome","year":"2001","unstructured":"Saotome M, Yoshitomi Y, Kojima S, Kuramochi M. Dilated cardiomyopathy of Becker-type muscular dystrophy with exon 4 deletion-a case report. Angiology. 2001;52:343\u20137.","journal-title":"Angiology."},{"key":"788_CR21","first-page":"62","volume":"46","author":"N Futamura","year":"2006","unstructured":"Futamura N, Kawamoto K, Takahashi K, Funakawa I, Jinnai K. Four siblings with Becker muscular dystrophy (BMD) manifesting severe mental retardation. Rinsho Shinkeigaku. 2006;46:62\u20135.","journal-title":"Rinsho Shinkeigaku."},{"key":"788_CR22","doi-asserted-by":"publisher","first-page":"e43515","DOI":"10.1371\/journal.pone.0043515","volume":"7","author":"EK Johnson","year":"2012","unstructured":"Johnson EK, Zhang L, Adams ME, et al. Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. PLoS ONE. 2012;7:e43515.","journal-title":"PLoS ONE"},{"key":"788_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/BF00266399","volume":"93","author":"H Tanaka","year":"1990","unstructured":"Tanaka H, Ikeya K, Ozawa E. Difference in the expression pattern of dystrophin on the surface membrane between the skeletal and cardiac muscles of mdx carrier mice. Histochemistry. 1990;93:447\u201352.","journal-title":"Histochemistry."},{"key":"788_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/jhg.2017.57","volume":"62","author":"A Nakamura","year":"2017","unstructured":"Nakamura A. Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy. J Hum Genet. 2017;62:871\u20136.","journal-title":"J Hum Genet"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-020-0788-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-020-0788-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-020-0788-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:09:11Z","timestamp":1684616951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-0788-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["788"],"URL":"https:\/\/doi.org\/10.1038\/s10038-020-0788-9","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"16 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}